Login

TAY TWO CO., LTD., based in West Japan, is a comprehensive second-hand retail company focused on reselling pre-owned goods. 00:10:00

Share On Facebook Share On Twitter

Yasuyoshi Mitsumoto is Board Member at Tay Two Co Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Navigating Direct Foreign Investment in Africa's Growing Economy
00:10:00
we are focused on discovering developing and commercializing novel gene and cell therapies and vaccines|Jon Lieber, Chief Financial Officer,Histogenics Corp
00:10:00
A Discussion on Decentralization and Renewable Technologies | Louis Maurice, CEO, Groupe Okwind SA.
00:10:00
Unraveling Business Potential: Insights from Chaiyaporn Kiatnawinlop, CEO of BOL
00:10:00
Bullish Outlook on Thailand's Stock Market: Insights from Doug Barnett, Director of Quest Management
00:10:00
EQT CEO Christian Sinding on Global Markets, Investment Strategies, and Future Opportunities | Christian Sinding, CEO, EQT.
00:10:00
"An Interview with Meb Faber, Chief Investment Officer of Cambria Investment Management"
00:10:00
Maptek's Peter Johnson Discusses Advancements in Mining Technology and Data Management
00:10:00
Blockchain Revolution: Kevin Soltani on the Future of Gaming and NFTs | Kevin Soltani, CEO, Semper Fortis Esports PLC.
00:10:00
Advancing Energy and Environmental Solutions: Insights from Babcock & Wilcox Executives | Babcock & Wilcox executives; Mohammed Helwee, Regional Director of Business Development and Sales
00:10:00
Patriot Lithium CEO Nicholas Vickery on Strategic Expansion in Ontario’s Electric Avenue | Nick Vickery ,CEO , Patriot Lithium Ltd.
00:10:00
Stephen Manderson, aka Professor Green, interviews Centrica CEO Chris O'Shea and CEO of the British Gas Energy Trust Jessica Taplin to discuss energy initiatives.

© 2026 Nehu